Trial
NCT01546896
Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety Disorder
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Seoul National University Hospital
Collaborators
—
Condition
Anxiety Disorder
Intervention
buspirone+alprazolam
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-05-20